Where Data Tells the Story
© Voronoi 2026. All rights reserved.
In the 2025 China Pharmaceutical Innovation and Invention Index, Hengrui leads both the Innovation and Invention rankings, underscoring its position as the country’s most balanced and research-driven pharma company.
Everest Medicines stands out as a rising force in China’s biopharmaceutical landscape, ranking 10th in invention and 23rd in innovation. The top 30 Chinese companies obtained 24 innovative drug approvals in 2024, with biologics accounting for half.